Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
HIV Activists Fight Against Federal Funding Cuts in Mississippi
Clinical & Pharma HIV Activists Fight Against Federal Funding Cuts in Mississippi

The ongoing battle against HIV in the United States faces significant challenges as federal funding cuts threaten vital prevention and treatment programs. In Mississippi, where health disparities are particularly pronounced, dedicated activists like Cedric Sturdevant have risen to the occasion,

Why Do 90% of Health Startups Hit Revenue Walls?
Tech & Innovation Why Do 90% of Health Startups Hit Revenue Walls?

The health innovation sector continues to witness an influx of startups, each eager to carve a niche in an ever-evolving industry characterized by technological advancements and innovative solutions. Despite the optimism driving the establishment of new ventures, an overwhelming majority face the

Modernizing Medicaid: Texting Reform Sparks Legislative Debate
Management & Administration Modernizing Medicaid: Texting Reform Sparks Legislative Debate

James Maitland is a leading voice in the intersection of healthcare and technology, with a remarkable ability to translate complex robotics and IoT applications into practical solutions for medical care advancement. Here, he shares insights on the pressing issue of updating managed care

Trend Analysis: AI Model Validation in Healthcare
Tech & Innovation Trend Analysis: AI Model Validation in Healthcare

In an era where precision and reliability in healthcare are paramount, the rise of artificial intelligence (AI) model validation is reshaping the medical landscape. This trend spotlights the transition from theoretical AI applications to practical implementations within the sector, promising

Trend Analysis: Health Budget Restructuring
Tech & Innovation Trend Analysis: Health Budget Restructuring

A seismic shift in the federal budget allocation for health services has been proposed, threatening to redefine vital aspects of public health infrastructure. The Trump administration's blueprint for a 25% cut in discretionary funding for the Department of Health and Human Services (HHS) by

BioNTech To Acquire CureVac, Boosting mRNA Cancer Therapies
Clinical & Pharma BioNTech To Acquire CureVac, Boosting mRNA Cancer Therapies

BioNTech, a leading force in the global pharmaceuticals industry, has embarked on a strategic acquisition of CureVac to solidify its position in mRNA-based cancer therapeutics. With this acquisition, the company looks to expand its capabilities beyond the notable success achieved with the COVID-19

Can AI and Value-Based Care Tackle the Chronic Disease Crisis?
Management & Administration Can AI and Value-Based Care Tackle the Chronic Disease Crisis?

The United States faces a daunting challenge with chronic diseases forming a significant share of deaths and disabilities due to poor management. These illnesses, including heart disease, cancer, diabetes, obesity, and hypertension, are responsible for five out of ten leading causes of mortality,

Is South Africa's NHI Act a Threat to Private Healthcare?
Management & Administration Is South Africa's NHI Act a Threat to Private Healthcare?

The National Health Insurance (NHI) Act in South Africa has become a focal point of heated debate, with significant implications for both the country's public and private healthcare sectors. At the heart of this issue is the legal challenge mounted by the Health Funders Association (HFA),

How Can We Enhance Health Beyond Medical Care?
Management & Administration How Can We Enhance Health Beyond Medical Care?

In the modern healthcare landscape, the realization that health is shaped by societal factors, known as social determinants of health, has gained momentum. Factors such as access to education, economic stability, housing, and food security play significant roles in influencing one's health

How are Digital Health Firms Tackling Economic Uncertainties?
Tech & Innovation How are Digital Health Firms Tackling Economic Uncertainties?

In an era marked by economic instability, digital health firms face unique challenges and opportunities. With fluctuations in tariffs, unpredictable regulatory climates, and market volatility, these companies are compelled to recalibrate their strategies to remain resilient and seize growth

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later